Trial Profile
A Double-Blind (3rd Party Open), Randomized, Placebo Controlled, Dose Escalating, Parallel Group Study To Investigate The Safety, Toleration And Pharmacokinetics Of Single Doses Of PF-04418948 In Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs PF 4418948 (Primary)
- Indications Endometriosis
- Focus Adverse reactions; Pharmacokinetics
- 22 Oct 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 22 Dec 2009 New trial record